(00:31) 
 Could you tell us a bit about yourself and your background?

(01:11)
 Could you describe these new tests and when it would be appropriate to use each of them in the clinic?

(03:16)
 Could you provide a little background on why MCL is making changes to the PLA2R test?

(04:34)
 Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?